Literature DB >> 7142426

An antibiotic susceptibility testing trial organised as part of the United Kingdom national external microbiological quality assessment scheme.

J J Snell, D F Brown, P S Gardner.   

Abstract

Organisms of known susceptibility to antimicrobial drugs were distributed for sensitivity testing to laboratories participating in the United Kingdom National External Microbiological Quality Assessment Scheme. The results obtained were correlated with the methods used. Laboratories differed in their standards of antimicrobial drug sensitivity testing. An association between error rates and particular methods and practices enabled recommendations to be made on disc content, method of methicillin testing, preparation of inoculum, use of controls and use of lysed blood for sulphonamide testing. Some media appeared significantly better than others but because of the many factors involved further information is being sought to clarify this.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7142426      PMCID: PMC497921          DOI: 10.1136/jcp.35.11.1169

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  Identification of Harper-Cawston factor as thymidine phosphorylase and removal from media of substances interfering with susceptibility testing to sulfonamides and diaminopyrimidines.

Authors:  R Ferone; S R Bushby; J J Burchall; W D Moore; D Smith
Journal:  Antimicrob Agents Chemother       Date:  1975-01       Impact factor: 5.191

2.  NATURALLY OCCURING METHICILLIN-RESISTANT STAPHYLOCOCCI.

Authors:  M BARBER
Journal:  J Gen Microbiol       Date:  1964-05

3.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

4.  The effect of temperature on resistance of Staphylococcus aureus to methicillin and some other antibioics.

Authors:  D I Annear
Journal:  Med J Aust       Date:  1968-03-16       Impact factor: 7.738

5.  Quality control in bacteriology: preliminary trials.

Authors:  E J Stokes; J L Whitby
Journal:  J Clin Pathol       Date:  1971-12       Impact factor: 3.411

6.  The United Kingdom national microbiological quality assessment scheme.

Authors:  J J Snell; J V De Mello; P S Gardner
Journal:  J Clin Pathol       Date:  1982-01       Impact factor: 3.411

  6 in total
  7 in total

1.  Antimicrobial susceptibility testing of Haemophilus influenzae: trial organised as part of United Kingdom national external quality assessment scheme for microbiology.

Authors:  J J Snell; D F Brown; T J Phua
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

2.  United Kingdom National External Quality Assessment Scheme for Microbiology.

Authors:  J J Snell
Journal:  Eur J Clin Microbiol       Date:  1985-10       Impact factor: 3.267

3.  Antimicrobial susceptibility testing of Neisseria gonorrhoeae: a trial organised as part of the United Kingdom national external quality assessment scheme for microbiology.

Authors:  J J Snell; D F Brown
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

4.  Comparison of antibiotic susceptibility results obtained with Adatab and disc methods.

Authors:  J J Snell; M V Danvers; P S Gardner
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

5.  Microbiological quality assessment and the clinician.

Authors:  P S Gardner
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-19

6.  Comparison of results from two antibiotic susceptibility testing trials that formed part of the United Kingdom national external quality assessment scheme.

Authors:  J J Snell; D F Brown; P S Gardner
Journal:  J Clin Pathol       Date:  1984-03       Impact factor: 3.411

Review 7.  Evolving approaches to management of quality in clinical microbiology.

Authors:  R C Bartlett; M Mazens-Sullivan; J Z Tetreault; S Lobel; J Nivard
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.